Marvin L White insider trades

Open-market stock purchases and sales by Marvin L White, Executive Chair at Aptevo Therapeutics Inc, from SEC Form 4 filings since Jun 1, 2010.

Track record: 60% of 5 scored buys are up 5% or more since purchase, averaging +41%.

Recent trades

DateStockTradeValue
Aug 6, 2026APVO Aptevo Therapeutics IncBought (not open market)—
Aug 6, 2026APVO Aptevo Therapeutics IncSold (not open market)$1.7K
Aug 6, 2026APVO Aptevo Therapeutics IncBought (not open market)—
Jul 17, 2026APVO Aptevo Therapeutics IncBought (not open market)—
Jul 17, 2026APVO Aptevo Therapeutics IncBought (not open market)—
Apr 30, 2026EBS Emergent BioSolutions IncBought (not open market)—
Apr 30, 2026EBS Emergent BioSolutions IncBought (not open market)—

Companies traded

  • APVO Aptevo Therapeutics Inc: 5 buys, 1 sale, last Aug 6, 2026
  • EBS Emergent BioSolutions Inc: 5 sales, last Apr 30, 2026
  • CLCD CoLucid Pharmaceuticals, Inc: other filings, last Mar 1, 2017
  • WPG WP Glimcher Inc: 2 buys, last May 17, 2016

Get free alerts when Marvin L White files a new trade →